Back to search

Netherlands· NL-f473e75e0b62

AKANTIOR 0,8 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruik

A polihexanide product containing polihexanide, registered in Netherlands by SIFI SpA. The same ATC class is registered in 9 of our 19 countries.

ATC S01AX24

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAKANTIOR 0,8 mg/ml oogdruppels, oplos…ATCS01AX24REGISTER NO.NL-f473e75e0b62PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Polihexanide is registered in 9 of 19 countries.

Countries holding a registration under ATC S01AX24 (polihexanide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Polihexanide · ATC S01AX24

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
POLIHEXANIDE
Manufacturer
SIFI SpA
Country
Netherlands (NL)
ATC code
S01AX24
ATC class
Polihexanide
Defined daily dose
4 Eindosisbeh
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1840

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Polihexanide in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All polihexanide products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Akantior
  • Norway · Akantior

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0c754f1a-ede1-4f22-80e0-17e0ad4ddbd0
GET /v1/drugs/0c754f1a-ede1-4f22-80e0-17e0ad4ddbd0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/akantior-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Polihexanide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130018",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "POLIHEXANIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/08/22",
  "procedure_number": "EMEA/H/C/005858",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1840",
  "additional_monitoring": "N"
}

See everything about polihexanide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.